Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Research Suggests Proton Pump Inhibitors May Help Limit Fibrosis in Eosinophilic Esophagitis
Research with Phoenix Children’s pediatric gastroenterologist Colby S. Sharlin, MD, as first author suggests PPIs may help limit scarring in eosinophilic esophagitis, not just inflammation.
The article examines the objective, findings, and clinical context described in Research Suggests Proton Pump Inhibitors May Help Limit Fibrosis in Eosinophilic Esophagitis.
Approach:
Research: The study, conducted in the Shoda Lab at Cincinnati Children’s Hospital Medical Center, examined PPI effects on remodeling and fibrosis using clinical cohorts and basic science experiments.
Clinical context: The article describes PPIs as a commonly used initial treatment for pediatric EoE and notes that treatment decisions at Phoenix Children’s involve shared decision-making and review of medical, nutritional, and developmental factors.
Monitoring: Follow-up evaluation, typically by sedated upper endoscopy, is used to assess treatment response. Sedation-free options described include transnasal endoscopy and the esophageal string test.
Key Findings:
The research reported anti-fibrotic properties of PPIs in clinical cohorts and basic science experiments.
EoE-related fibrosis can progress to esophageal strictures, which may impair quality of life and sometimes require dilation.
Choking or food impaction may indicate fibrosis; endoscopy can show narrowing, strictures, or rings, while biopsy may detect microscopic changes not visible during endoscopy.
Interpretation:
The study adds evidence that PPIs may have effects beyond acid reduction and inflammation control, potentially including limiting esophageal scarring in EoE. The article notes that further research should examine combination therapies and precision-medicine strategies for PPI use in children and adults.
Limitations:
The provided article context does not report study design details, cohort sizes, effect estimates, or specific experimental results.
The article describes the findings as suggesting a potential anti-fibrotic effect; it does not establish the extent of clinical benefit.
Conclusion:
The article presents PPIs as a treatment option under study for limiting fibrosis in EoE and emphasizes follow-up evaluation to assess whether treatment is working.
UK pilot study finds that whole genome sequencing can uncover genetic conditions in children, leading to changes in clinical management and specialist care